Source: Circulation. Journal of the american heart association. Unidade: FM
Subjects: INFARTO DO MIOCÁRDIO, ANGIOPLASTIA, PLAQUETAS SANGUÍNEAS, ANGINA INSTÁVEL
ABNT
MORROW, David A. et al. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the trial to assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With prasugrel-thrombolysis in myocardial infarction 38: an application of the classification system from the universal definition of myocardial infarction. Circulation. Journal of the american heart association, v. 119, n. 21, p. 2758-2764, 2009Tradução . . Acesso em: 15 nov. 2024.APA
Morrow, D. A., Wiviott, S. D., White, H. D., Nicolau, J. C., Bramucci, E., Murphy, S. A., et al. (2009). Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the trial to assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With prasugrel-thrombolysis in myocardial infarction 38: an application of the classification system from the universal definition of myocardial infarction. Circulation. Journal of the american heart association, 119( 21), 2758-2764.NLM
Morrow DA, Wiviott SD, White HD, Nicolau JC, Bramucci E, Murphy SA, Farias A, Bonaca MP, Ruff CT, Scirica BM, McCabe CH, Antman EM, Braunwald E. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the trial to assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With prasugrel-thrombolysis in myocardial infarction 38: an application of the classification system from the universal definition of myocardial infarction. Circulation. Journal of the american heart association. 2009 ; 119( 21): 2758-2764.[citado 2024 nov. 15 ]Vancouver
Morrow DA, Wiviott SD, White HD, Nicolau JC, Bramucci E, Murphy SA, Farias A, Bonaca MP, Ruff CT, Scirica BM, McCabe CH, Antman EM, Braunwald E. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the trial to assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With prasugrel-thrombolysis in myocardial infarction 38: an application of the classification system from the universal definition of myocardial infarction. Circulation. Journal of the american heart association. 2009 ; 119( 21): 2758-2764.[citado 2024 nov. 15 ]